Cognitive and Metabolic Effects of a Probiotic Supplement

NCT ID: NCT02005003

Last Updated: 2014-11-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-11-30

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To examine the cognitive and metabolic effects of a probiotic supplement that is readily and already available for purchase in public drug stores. This study is a double-blinded randomized cross-over placebo-controlled intervention study. Participants will be randomized to receive either the probiotic supplement or the placebo during the first intervention period which will last 2 weeks. This will be followed by a washout period, after which they will proceed to the second intervention period, also lasting 2 weeks and also followed by a washout period.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dietary Supplements Probiotics Metabolism Food Preferences Microbiota

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Probiotic

Probiotic pills given for 2 weeks, during one of the interventions that the participants is either randomized to as the first or second intervention period. At day 0 and following each intervention period (at week 2 and week 6), participants will be tested using Inhibitory task, Blood samples, Feces collection, Caloric preload, Food selection task, Memory task and Food consumption task.

Group Type ACTIVE_COMPARATOR

Inhibitory task

Intervention Type BEHAVIORAL

Participants perform a binary decision on each presented stimuli. Of the two possible outcomes, participants are instructed to make a motor response (go) for one type, and are to withhold a response (no-go) for the other type. Reaction time and accuracy are measured for each event

Blood samples

Intervention Type PROCEDURE

Hormone levels will be analyzed from blood samples obtained before and after a caloric preload given at each visit

Feces collection

Intervention Type BIOLOGICAL

Feces samples will be collected on the morning of each visit, before and after each 2-week intervention period, as well as after each 2-week washout period following each intervention period.

Caloric preload

Intervention Type PROCEDURE

A caloric preload will be given to participants, following which blood will be taken at 65 minutes later (specified in Blood sampling) following the ingestion of the caloric preload.

Food selection task

Intervention Type BEHAVIORAL

Participants are given the opportunity to write and use a computer program to specify amount and type of food would ideally like to consume

Memory task

Intervention Type BEHAVIORAL

Participants perform short memory tasks on each visit

Food consumption task

Intervention Type BEHAVIORAL

Participants are given a selection of food items to consume on each visit

Placebo

Placebo pills given for 2 weeks, during one of the interventions that the participants is either randomized to as the first or second intervention period. At day 0 and following each intervention period (at week 2 and week 6), participants will be tested using Inhibitory task, Blood samples, Feces collection, Caloric preload, Food selection task, Memory task and Food consumption task.

Group Type PLACEBO_COMPARATOR

Inhibitory task

Intervention Type BEHAVIORAL

Participants perform a binary decision on each presented stimuli. Of the two possible outcomes, participants are instructed to make a motor response (go) for one type, and are to withhold a response (no-go) for the other type. Reaction time and accuracy are measured for each event

Blood samples

Intervention Type PROCEDURE

Hormone levels will be analyzed from blood samples obtained before and after a caloric preload given at each visit

Feces collection

Intervention Type BIOLOGICAL

Feces samples will be collected on the morning of each visit, before and after each 2-week intervention period, as well as after each 2-week washout period following each intervention period.

Caloric preload

Intervention Type PROCEDURE

A caloric preload will be given to participants, following which blood will be taken at 65 minutes later (specified in Blood sampling) following the ingestion of the caloric preload.

Food selection task

Intervention Type BEHAVIORAL

Participants are given the opportunity to write and use a computer program to specify amount and type of food would ideally like to consume

Memory task

Intervention Type BEHAVIORAL

Participants perform short memory tasks on each visit

Food consumption task

Intervention Type BEHAVIORAL

Participants are given a selection of food items to consume on each visit

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Inhibitory task

Participants perform a binary decision on each presented stimuli. Of the two possible outcomes, participants are instructed to make a motor response (go) for one type, and are to withhold a response (no-go) for the other type. Reaction time and accuracy are measured for each event

Intervention Type BEHAVIORAL

Blood samples

Hormone levels will be analyzed from blood samples obtained before and after a caloric preload given at each visit

Intervention Type PROCEDURE

Feces collection

Feces samples will be collected on the morning of each visit, before and after each 2-week intervention period, as well as after each 2-week washout period following each intervention period.

Intervention Type BIOLOGICAL

Caloric preload

A caloric preload will be given to participants, following which blood will be taken at 65 minutes later (specified in Blood sampling) following the ingestion of the caloric preload.

Intervention Type PROCEDURE

Food selection task

Participants are given the opportunity to write and use a computer program to specify amount and type of food would ideally like to consume

Intervention Type BEHAVIORAL

Memory task

Participants perform short memory tasks on each visit

Intervention Type BEHAVIORAL

Food consumption task

Participants are given a selection of food items to consume on each visit

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male
* Age 18-28y
* Healthy (self-reported) and not on medication
* Non-smoking
* Normal sleep-wake rhythm (i.e. 7-8 h per night, self-reported via diaries)
* Regular meal patterns with daily breakfast

Exclusion Criteria

* Major illness
* Taking any serious medications
* Any sleep conditions (e.g. irregular bedtimes, sleep complaints)
* Any dietary issues with the food items provided
* Current or history of endocrine, neurological or psychiatric disorders
* Shift work in the preceding three months or for a long duration
* Time travel over a significant number of time zones in the preceding two months
* Too much weight gain or weight loss in the preceding three months
* Excessive intake of fermented dairy products
* Intake of probiotics
* Recent antibiotic treatment (last 6 months)
* Recent intake of certain dietary supplements
* Excessive caffeine (\>5 cups daily) or alcohol intake (\>2 alcohol units daily)
Minimum Eligible Age

18 Years

Maximum Eligible Age

28 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Uppsala University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jonathan Cedernaes

Medical doctor, PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christian Benedict, PhD

Role: PRINCIPAL_INVESTIGATOR

Department of Neuroscience, Uppsala University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Neuroscience, Uppsala University

Uppsala, , Sweden

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jonathan Cedernaes, M.D., PhD

Role: CONTACT

Christian Benedict, PhD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jonathan Cedernaes, M.D., PhD

Role: primary

Christian Benedict, PhD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FF8vsPlaceboJC2013

Identifier Type: -

Identifier Source: org_study_id